<?xml version="1.0" encoding="UTF-8"?>
<funding-group>
 <award-group id="gs1">
  <funding-source id="sp1">DOD | Defense Threat Reduction Agency (DTRA)
   <named-content content-type="funder-id">100000774</named-content>
  </funding-source>
  <award-id rid="sp1">HDTRA1-15-1-0067</award-id>
  <principal-award-recipient>David Markovitz</principal-award-recipient>
 </award-group>
 <award-group id="gs2">
  <funding-source id="sp2">HHS | National Institutes of Health (NIH)
   <named-content content-type="funder-id">100000002</named-content>
  </funding-source>
  <award-id rid="sp2">T32 GM07863</award-id>
  <principal-award-recipient>Evelyn M Covés-Datson</principal-award-recipient>
 </award-group>
 <award-group id="gs3">
  <funding-source id="sp3">HHS | National Institutes of Health (NIH)
   <named-content content-type="funder-id">100000002</named-content>
  </funding-source>
  <award-id rid="sp3">T32 AI007528</award-id>
  <principal-award-recipient>Evelyn M Covés-Datson</principal-award-recipient>
 </award-group>
 <award-group id="gs4">
  <funding-source id="sp4">HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
   <named-content content-type="funder-id">100000060</named-content>
  </funding-source>
  <award-id rid="sp4">1F31AI136615-01</award-id>
  <principal-award-recipient>Evelyn M Covés-Datson</principal-award-recipient>
 </award-group>
 <award-group id="gs5">
  <funding-source id="sp5">University of Michigan (U-M)
   <named-content content-type="funder-id">100007270</named-content>
  </funding-source>
  <award-id rid="sp5">Michigan Translational Research and Commercialization (MTRAC) Life Sciences</award-id>
  <principal-award-recipient>David Markovitz</principal-award-recipient>
 </award-group>
</funding-group>
